2 completed, 1 terminated, 1 unknown. 4 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 2, Terminated 1, Unknown 1 |
| Phase 1 | 1 | Unknown 1 |
Follow Hematopoietic Neoplasm: new trials by email Literature Review of Hematopoietic Neoplasm trials Research Report on Hematopoietic Neoplasm
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| GVHD Prophylaxis With Methotrexate in Haploidentical HCT Using Posttransplant Cyclophosphamide Methotrexate Injectable Solution - Graft Vs Host Disease, Hematopoietic Neoplasm | Phase 1 / Phase 2 | Unknown | University of Sao Paulo General Hospital | 47 | 2020-10-07 | 2021-09-14 |
| Phase II, Open Label, Single Arm Study of SAR302503 In Myelofibrosis Patients Previously Treated With Ruxolitinib SAR302503 - Hematopoietic Neoplasm | Phase 2 | Terminated | Bristol-Myers Squibb | 97 | 2012-04-30 | 2026-07-16 |
| Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia SAR302503 - Hematopoietic Neoplasm | Phase 2 | Completed | Bristol-Myers Squibb | 81 | 2011-10-01 | 2025-03-05 |
| Phase 2 Study of SAR302503 in Patients With Myelofibrosis SAR302503 - Hematopoietic Neoplasm | Phase 2 | Completed | Bristol-Myers Squibb | 30 | 2011-08-01 | 2025-03-05 |
Hematologic Neoplasms (4) · Graft vs Host Disease (1)
Hematologic Diseases (4) · Hemic and Lymphatic Diseases (4) · Neoplasms (4) · Neoplasms by Site (4) · Immune System Diseases (1)
fedratinib (3)
Bristol-Myers Squibb (3) · University of Sao Paulo General Hospital (1)
United States (3) · Canada (2) · France (2) · Germany (2) · Italy (2) · Spain (2) · United Kingdom (2) · Australia (1) · Austria (1) · Belgium (1) · Brazil (1) · Netherlands (1) · South Korea (1)